As of the latest Form 4 filed Jul 10, 2026.
What BeiGene, Ltd. insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 90 most recent filings for ONC.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-10 | 2026-07-08 | Lee Chan Henry SVP, General Counsel | SSale | −664.00 | $302.46 | $201K | Yes (planned) | Form 4 ↗ |
| 2026-07-10 | 2026-07-08 | Lee Chan Henry, SVP, General Counsel | MExercise | +196.00 | $159.03 | $31.2K | Yes (planned) | Form 4 ↗ |
| 2026-07-10 | 2026-07-08 | Lee Chan Henry, SVP, General Counsel | MExercise | +266.00 | $213.32 | $56.7K | Yes (planned) | Form 4 ↗ |
| 2026-07-10 | 2026-07-08 | Lee Chan Henry, SVP, General Counsel | MExercise | +202.00 | $194.47 | $39.3K | Yes (planned) | Form 4 ↗ |
| 2026-06-25 | 2026-06-23 | Wang Lai President, Global Head of R&D | SSale | −1.07K | $276.74 | $296K | No | Form 4 ↗ |
| 2026-06-25 | 2026-06-23 | Wu Xiaobin President and COO | SSale | −1.29K | $276.26 | $357K | No | Form 4 ↗ |
| 2026-06-25 | 2026-06-23 | OYLER JOHN Chief Executive Officer | SSale | −320.00 | $275.10 | $88.0K | No | Form 4 ↗ |
| 2026-06-25 | 2026-06-23 | OYLER JOHN, Chief Executive Officer | SSale | −1.29K | $274.12 | $354K | No | Form 4 ↗ |
| 2026-06-25 | 2026-06-23 | OYLER JOHN, Chief Executive Officer | SSale | −1.80K | $273.30 | $492K | No | Form 4 ↗ |
| 2026-06-18 | 2026-06-16 | Lee Chan Henry SVP, General Counsel | SSale | −590.00 | $265.98 | $157K | No | Form 4 ↗ |
| 2026-06-18 | 2026-06-16 | Wang Lai President, Global Head of R&D | SSale | −1.17K | $265.39 | $310K | No | Form 4 ↗ |
| 2026-06-18 | 2026-06-16 | Wu Xiaobin President and COO | SSale | −1.36K | $266.76 | $362K | No | Form 4 ↗ |
| 2026-06-18 | 2026-06-16 | OYLER JOHN Chief Executive Officer | SSale | −333.00 | $266.69 | $88.8K | No | Form 4 ↗ |
| 2026-06-18 | 2026-06-16 | OYLER JOHN, Chief Executive Officer | SSale | −1.71K | $265.99 | $455K | No | Form 4 ↗ |
| 2026-06-18 | 2026-06-16 | OYLER JOHN, Chief Executive Officer | SSale | −1.65K | $264.87 | $437K | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Mooney Elizabeth Fisher Director | AAward | +19.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Sawyers Charles Lazelle Director | AAward | +19.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Rosenberg Aaron Chief Financial Officer | SSale | −631.00 | $257.74 | $163K | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Rosenberg Aaron, Chief Financial Officer | AAward | +71.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Lee Chan Henry SVP, General Counsel | SSale | −428.00 | $257.64 | $110K | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Lee Chan Henry, SVP, General Counsel | AAward | +45.1K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Dugan Margaret Director | AAward | +19.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Riva Alessandro Director | AAward | +19.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Wang Lai President, Global Head of R&D | SSale | −756.00 | $261.00 | $197K | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Wang Lai, President, Global Head of R&D | AAward | +119K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Wu Xiaobin President and COO | SSale | −626.00 | $261.20 | $164K | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Wu Xiaobin, President and COO | AAward | +119K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Ball Titus B. Principal Accounting Officer | SSale | −120.00 | $257.53 | $30.9K | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Ball Titus B., Principal Accounting Officer | SSale | −49.00 | $256.39 | $12.6K | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Ball Titus B., Principal Accounting Officer | AAward | +31.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Wang Xiaodong Director | AAward | +99.9K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | BRANDICOURT OLIVIER Director | AAward | +19.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Sharp Shalini Director | AAward | +19.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | HOOPER ANTHONY C Director | AAward | +19.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | BAKER BROS. ADVISORS LP Director | AAward | +19.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | BAKER BROS. ADVISORS LP, Director | AAward | +19.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | OYLER JOHN Chief Executive Officer | SSale | −149.00 | $258.81 | $38.6K | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | OYLER JOHN, Chief Executive Officer | SSale | −200.00 | $258.28 | $51.7K | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | OYLER JOHN, Chief Executive Officer | SSale | −859.00 | $257.59 | $221K | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | OYLER JOHN, Chief Executive Officer | SSale | −741.00 | $256.23 | $190K | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | OYLER JOHN, Chief Executive Officer | AAward | +178K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | Lee Chan Henry SVP, General Counsel | SSale | −160.00 | $271.26 | $43.4K | No | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | Lee Chan Henry, SVP, General Counsel | SSale | −711.00 | $270.24 | $192K | No | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | Wang Lai President, Global Head of R&D | SSale | −40.00 | $270.73 | $10.8K | No | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | Wang Lai, President, Global Head of R&D | SSale | −1.33K | $269.34 | $357K | No | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | Wu Xiaobin President and COO | SSale | −40.00 | $270.55 | $10.8K | No | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | Wu Xiaobin, President and COO | SSale | −1.44K | $269.33 | $389K | No | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | Ball Titus B. Principal Accounting Officer | SSale | −36.00 | $272.08 | $9.79K | No | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | Ball Titus B., Principal Accounting Officer | SSale | −100.00 | $271.06 | $27.1K | No | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | OYLER JOHN Chief Executive Officer | SSale | −1.12K | $271.14 | $304K | No | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | OYLER JOHN, Chief Executive Officer | SSale | −3.82K | $270.38 | $1.03M | No | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Yi Qingqing Director | SSale | −235.00 | $279.13 | $65.6K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-22 | Dugan Margaret Director | SSale | −212.00 | $309.60 | $65.6K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-22 | Riva Alessandro Director | SSale | −212.00 | $309.51 | $65.6K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-22 | Sanders Corazon (Corsee) D. Director | SSale | −212.00 | $309.59 | $65.6K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-22 | BAKER BROS. ADVISORS LP Director | SSale | −2.76K | $23.79 | $65.6K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-22 | BAKER BROS. ADVISORS LP, Director | SSale | −2.76K | $23.79 | $65.6K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-22 | BAKER BROS. ADVISORS LP, Director | SSale | −2.74K | $23.85 | $65.4K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-22 | BAKER BROS. ADVISORS LP, Director | SSale | −2.74K | $23.85 | $65.4K | No | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | Lee Chan Henry SVP, General Counsel | SSale | −332.00 | $310.72 | $103K | Yes (planned) | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | Lee Chan Henry, SVP, General Counsel | MExercise | +98.00 | $159.03 | $15.6K | Yes (planned) | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | Lee Chan Henry, SVP, General Counsel | MExercise | +133.00 | $213.32 | $28.4K | Yes (planned) | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | Lee Chan Henry, SVP, General Counsel | MExercise | +101.00 | $194.47 | $19.6K | Yes (planned) | Form 4 ↗ |
| 2026-04-10 | 2026-04-08 | Lee Chan Henry SVP, General Counsel | SSale | −332.00 | $311.59 | $103K | Yes (planned) | Form 4 ↗ |
| 2026-04-10 | 2026-04-08 | Lee Chan Henry, SVP, General Counsel | MExercise | +98.00 | $159.03 | $15.6K | Yes (planned) | Form 4 ↗ |
| 2026-04-10 | 2026-04-08 | Lee Chan Henry, SVP, General Counsel | MExercise | +133.00 | $213.32 | $28.4K | Yes (planned) | Form 4 ↗ |
| 2026-04-10 | 2026-04-08 | Lee Chan Henry, SVP, General Counsel | MExercise | +101.00 | $194.47 | $19.6K | Yes (planned) | Form 4 ↗ |
| 2026-03-13 | 2026-03-11 | Lee Chan Henry SVP, General Counsel | SSale | −341.00 | $300.00 | $102K | Yes (planned) | Form 4 ↗ |
| 2026-03-13 | 2026-03-11 | Lee Chan Henry, SVP, General Counsel | MExercise | +98.00 | $159.03 | $15.6K | Yes (planned) | Form 4 ↗ |
| 2026-03-13 | 2026-03-11 | Lee Chan Henry, SVP, General Counsel | MExercise | +133.00 | $213.32 | $28.4K | Yes (planned) | Form 4 ↗ |
| 2026-03-13 | 2026-03-11 | Lee Chan Henry, SVP, General Counsel | MExercise | +110.00 | $194.47 | $21.4K | Yes (planned) | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | Rosenberg Aaron Chief Financial Officer | AAward | +40.6K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | Rosenberg Aaron, Chief Financial Officer | AAward | +79.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | Lee Chan Henry SVP, General Counsel | AAward | +29.9K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | Lee Chan Henry, SVP, General Counsel | AAward | +65.4K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | Wang Lai President, Global Head of R&D | AAward | +55.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | Wang Lai, President, Global Head of R&D | AAward | +113K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | Wu Xiaobin President and COO | AAward | +78.6K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | Wu Xiaobin, President and COO | AAward | +169K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | OYLER JOHN Chief Executive Officer | AAward | +118K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | OYLER JOHN, Chief Executive Officer | AAward | +327K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-06 | 2026-02-04 | Lee Chan Henry SVP, General Counsel | SSale | −996.00 | $350.00 | $349K | Yes (planned) | Form 4 ↗ |
| 2026-02-06 | 2026-02-04 | Lee Chan Henry, SVP, General Counsel | SSale | −664.00 | $348.79 | $232K | Yes (planned) | Form 4 ↗ |
| 2026-02-06 | 2026-02-04 | Lee Chan Henry, SVP, General Counsel | MExercise | +496.00 | $159.03 | $78.9K | Yes (planned) | Form 4 ↗ |
| 2026-02-06 | 2026-02-04 | Lee Chan Henry, SVP, General Counsel | MExercise | +662.00 | $213.32 | $141K | Yes (planned) | Form 4 ↗ |
| 2026-02-06 | 2026-02-04 | Lee Chan Henry, SVP, General Counsel | MExercise | +502.00 | $194.47 | $97.6K | Yes (planned) | Form 4 ↗ |
| 2026-01-09 | 2026-01-07 | Lee Chan Henry SVP, General Counsel | SSale | −664.00 | $331.76 | $220K | Yes (planned) | Form 4 ↗ |
| 2026-01-09 | 2026-01-07 | Lee Chan Henry, SVP, General Counsel | MExercise | +196.00 | $159.03 | $31.2K | Yes (planned) | Form 4 ↗ |
| 2026-01-09 | 2026-01-07 | Lee Chan Henry, SVP, General Counsel | MExercise | +266.00 | $213.32 | $56.7K | Yes (planned) | Form 4 ↗ |
| 2026-01-09 | 2026-01-07 | Lee Chan Henry, SVP, General Counsel | MExercise | +202.00 | $194.47 | $39.3K | Yes (planned) | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also ONC’s full analysis or the market-wide insider trading feed. The tabs above jump to ONC’s other SEC data.
Source: SEC Form 4 filings for ONC, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.